Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Gut and liver (2020) Chang CH, Tsai WC, et al
If you have underlying health conditions or are on long-term medication, sharing this information helps in avoiding complications
These fluctuations in temperature can damage the medication, reducing its effectiveness or making it unsafe to use
Retatrutide (LY3437943) is an investigational medicinal product (IMP) a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors currently under clinical evaluation for obesity and metabolic disease
Its efficacy was confirmed by a meta-analysis published recently in the Mayo Clinic Proceedings
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
